(Q38267736)

1 September 2017

1 reference

23 September 2020

Germ cell tumour chemotherapy (English)

1 reference

germ cell and embryonal neoplasms

1 September 2017

1 reference

antineoplastic combined chemotherapy protocols

23 September 2020

1 reference

23 September 2020

Horwich A

1

1 reference

PMCID

2246990

1 September 2017

language of work or name

English

0 references

publication date

1 February 1989

4 references

British Journal of Cancer

1 September 2017

3 April 2019

25 June 2019

23 September 2020

4 references

1 September 2017

3 April 2019

25 June 2019

23 September 2020

59

1 reference

1 September 2017

156-159

1 reference

1 September 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1989.33

1 September 2017

0 references

cites work

The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246990

Phase I studies with carboplatin at the Royal Marsden Hospital

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246990

Chemotherapy with maximally tolerable doses of VP 16-213 and cyclophosphamide followed by autologous bone marrow transplantation for the treatment of relapsed or refractory germ cell tumors.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246990

The effect of intensity of administered treatment on the outcome of germ cell tumours treated with POMB/ACE chemotherapy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246990

Long-term outcome in patients with germ cell tumours treated with POMB/ACE chemotherapy: comparison of commonly used classification systems of good and poor prognosis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246990

Chemotherapy of disseminated testicular cancer a random prospective study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246990

The clinical significance of flow cytometric c-myc oncoprotein quantitation in testicular cancer

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246990

Cyclic chemotherapy with cyclophosphamide, doxorubicin, and cisplatin plus vinblastine and bleomycin in advanced germinal tumors. Results with 100 patients

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246990

High-dose cisplatin and VP-16 with bleomycin, in the management of advanced metastatic germ cell tumors

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246990

Effects of cisplatin on different measures of glomerular function in the human kidney with special emphasis on high-dose.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246990

Chemotherapy for poor risk germ cell tumours. An independent evaluation of the POMB/ACE regime.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246990

A randomized trial of standard chemotherapy v a high-dose chemotherapy regimen in the treatment of poor prognosis nonseminomatous germ-cell tumors.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246990

Multivariate analysis of prognostic factors in patients with disseminated nonseminomatous testicular cancer: results from a European Organization for Research on Treatment of Cancer Multiinstitutional Phase III Study.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246990

Current optimum management of anaplastic germ cell tumours of the testis and other sites.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246990

Prognostic factors for favorable outcome in disseminated germ cell tumors

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246990

Multivariate analysis of prognostic variables in patients with metastatic testicular cancer.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246990

Comparison of criteria for assigning germ cell tumor patients to "good risk" and "poor risk" studies

31 August 2018

1 reference

12 December 2020

Cytoreductive Surgery for Metastatic Testis Cancer: Tissue Analysis of Retroperitoneal Masses after Chemotherapy

1 reference

12 December 2020

The management of advanced testicular teratoma

1 reference

12 December 2020

A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors

1 reference

12 December 2020

Cisplatin-based combination chemotherapy for disseminated germ cell tumors: long-term follow-up

1 reference

12 December 2020

Vincristine, cisplatin, and bleomycin with surgery in the management of advanced metastatic nonseminomatous testis tumors

1 reference

12 December 2020

High-Dose Cisplatin in Hypertonic Saline

1 reference

12 December 2020

Dose-response and dose-survival advantage for high versus low-dose cisplatin combined with vinblastine and bleomycin in disseminated testicular cancer a southwest oncology group study

1 reference

12 December 2020

Improved survival with cyclic chemotherapy for nonseminomatous germ cell tumors of the testis

1 reference

12 December 2020

Etoposide and cisplatin with or without bleomycin as first-line chemotherapy for patients with small-volume metastases of testicular nonseminoma

1 reference

12 December 2020

Cisplatin, etoposide, bleomycin first-line therapy and early resection of residual tumor in far-advanced germinal testis cancer

1 reference

12 December 2020

Alternating cycles of etoposide plus cisplatin and VAB-6 in the treatment of poor-risk patients with germ cell tumors

1 reference

12 December 2020

Have new aggressive chemotherapy regimens improved results in advanced germ cell tumors?

1 reference

12 December 2020

Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide

1 reference

12 December 2020

The role of surgery in the combined management of metastases from malignant teratomas of testis

1 reference

12 December 2020

The role of maintenance therapy in disseminated testicular cancer

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1989.33

1 reference

PMCID

2246990

Dimensions Publication ID

1 September 2017

0 references

1 reference

1 September 2017

1 reference

PMCID

2246990